D. E. Shaw & Co., Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $18.4 Million - $19.4 Million	-127,073 Reduced 55.55%	101,674 $15.4 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $18.4 Million - $32.3 Million	221,116 Added 2897.6%	228,747 $33.3 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $4.77 Million - $6.2 Million	-43,376 Reduced 85.04%	7,631 $905,000
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $6.95 Million - $10.3 Million	-69,703 Reduced 57.74%	51,007 $7.03 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $7.18 Million - $10.1 Million	72,656 Added 151.2%	120,710 $16.8 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $5.94 Million - $9.48 Million	-90,281 Reduced 65.26%	48,054 $4.67 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $1.61 Million - $2.31 Million	-25,174 Reduced 15.4%	138,335 $9.46 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $1.07 Million - $1.61 Million	-16,388 Reduced 9.11%	163,509 $14 Million
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $3.3 Million - $4.36 Million	55,957 Added 45.15%	179,897 $11.7 Million
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $433,902 - $1.11 Million	-14,957 Reduced 10.77%	123,940 $9.06 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $72,406 - $150,787	2,632 Added 1.93%	138,897 $4.73 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $2.41 Million - $3.4 Million	-58,989 Reduced 30.21%	136,265 $7.42 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $1.56 Million - $2.06 Million	-41,662 Reduced 17.59%	195,254 $8.15 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $7.87 Million - $13.3 Million	197,879 Added 506.9%	236,916 $10.4 Million
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $1.35 Million - $2.08 Million	39,037 New	39,037 $2.01 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account